Robert W O'Rourke
Manage Your Profile
About
Robert W. O'Rourke, MD serves as the William J. Fry Professor of Surgery in the Department of Surgery at the University of Michigan. He graduated from the Massachusetts Institute of Technology in Cambridge, MA with degrees in Chemical Engineering and Molecular Biology. He obtained his MD from the UCLA Medical School in Los Angeles, CA, completed general surgery residency training at UCSF in San Francisco, CA, and completed an Advanced Minimally Invasive Surgery Fellowship at Legacy Health Systems in Portland, OR. He spent ten years as faculty member and Co-Director of the Bariatric Surgery Program in the Department of Surgery at Oregon Health & Science University in Portland, OR prior to joining the University of Michigan in 2013.
Dr. O’Rourke has dedicated his clinical and scientific career to the care of patients with obesity and metabolic disease. He manages an NIH-funded research laboratory that studies molecular and cellular mechanisms of adipose tissue dysfunction that contribute to the pathogenesis of metabolic disease. The O'Rourke lab focuses on the role of the extracellular matrix in regulating adipocyte metabolic dysfunction in the context of diabetes, macrophage and NK cell contributions to adipose tissue inflammation and metabolism, and mechanistic links between adipose tissue dysfunction and cancer in the context of obesity. The overarching goal of this work is to develop novel cellular and molecular adipose tissue-based therapies for diabetes, dyslipidemia, cancer, and other metabolic diseases.
Dr. O'Rourke currently holds clinical appointments at the University of Michigan and the Ann Arbor Veterans Administration Hospital. He has served as Chief of General Surgery and Director of the Bariatric Surgery Program at the Ann Arbor VA since 2018. His primary clinical focus is minimally invasive and bariatric surgery. He is active in resident and medical student education and serves as an active member of multiple national surgical societies and on the editorial boards of the journals Obesity Surgery and SOARD.
Center Memberships
-
Center MemberCaswell Diabetes Institute
Research Overview
Molecular and cellular mechanisms of adipose tissue dysfunction in the context of diabetes
Extracellular matrix-adipocyte metabolic crosstalk
Adipocyte-cancer crosstalk
Recent Publications
-
Malhotra D, Henderson J, Turner CD, O'Rourke RW, McAuley KB, Heisler M, Otto M, Thomason C, O'Neill JL, Freeman K, Dunham MW, Bartley EP, Hess A, Kruse V, Ruttan K, Haeussler AL, Solomon G, Grondin C, Kim PS, Schildhouse RJ, Tremblay A, Griauzde DH. Primary Health Care Research Development, 2026 Jan 12; 27: e9Journal ArticleDeveloping a Weight Management and Metabolic Health Program to support patient-centred, effective, and efficient treatment for veterans with overweight or obesity: protocol for a quality improvement programme
DOI:10.1017/S1463423625100650 PMID: 41521639 -
Kwon JJ, Li J, Liu JYC, Patsalis C, Wu P, Kawase YH, Ky A, Pasternak C, Mason DD, Bozadjieva-Kramer N, Loebel C, Lumeng CN, O’Rourke RW. International Journal of Molecular Sciences, 2025 Nov 1; 26 (22):Journal ArticleA Hydrogel Culture System Regulates Human Adipocyte Function
DOI:10.3390/ijms262210865 PMID: 41303352 -
Wean J, Baranwal S, Miller N, Shin JH, O'Rourke RW, Burant CF, Seeley RJ, Rothberg AE, Bozadjieva-Kramer N. Diabetes and Metabolism, 2024 Sep 1; 50 (5):Journal ArticleGut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss
DOI:10.1016/j.diabet.2024.101570 PMID: 39134173 -
Kang Q, Zhu X, Ren D, Ky A, MacDougald OA, O'Rourke RW, Rui L. Advanced Science, 2023 Oct 6; 10 (28):Journal ArticleAdipose METTL14-Elicited N6-Methyladenosine Promotes Obesity, Insulin Resistance, and NAFLD Through Suppressing β Adrenergic Signaling and Lipolysis
DOI:10.1002/advs.202301645 PMID: 37526326 -
Ky A, McCoy AJ, Flesher CG, Friend NE, Li J, Akinleye K, Patsalis C, Lumeng CN, Putnam AJ, O’Rourke RW. Adipocyte, 2023 Jan 1; 12 (1):Journal ArticleMatrix density regulates adipocyte phenotype
DOI:10.1080/21623945.2023.2268261 PMID: 37815174 -
Strieder-Barboza C, Flesher CG, Geletka LM, Delproposto JB, Eichler T, Akinleye O, Ky A, Ehlers AP, O’Rourke RW, Lumeng CN. 2022 Jul 1; bioRxiv,PreprintSingle-nuclei Transcriptome of Human AT Reveals Metabolically Distinct Depot-Specific Adipose Progenitor Subpopulations
DOI:10.1101/2022.06.29.496888 -
Muir LA, Cho KW, Geletka L, Baker NA, Flesher CG, Ehlers AP, Kaciroti N, Lindsly S, Ronquist S, Rajapakse I, O'Rourke RW, Lumeng CN. JCI Insight, 2022 Feb 8; 7 (3):Journal ArticleHuman CD206+ macrophages associate with diabetes and adipose tissue lymphoid clusters
-
Strieder-Barboza , Flesher CG, Geletka LM, Eichler T, Akinleye O, Ky A, Ehlers AP, Lumeng CN, O’Rourke RW. Adipocyte, 2022 Jan 1; 11 (1): 665 - 675.Journal ArticleLumican modulates adipocyte function in obesity-associated type 2 diabetes
DOI:10.1080/21623945.2022.2154112 PMID: 36457256